25 XP   0   0   10

Divi's Laboratories Limited
Buy, Hold or Sell?

Let's analyse Divi's Laboratories Limited together

PenkeI guess you are interested in Divi's Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Divi's Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Divi's Laboratories Limited

I send you an email if I find something interesting about Divi's Laboratories Limited.

Quick analysis of Divi's Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Divi's Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR1.44
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR480.93
Expected worth in 1 year
INR637.47
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR276.54
Return On Investment
8.0%

For what price can you sell your share?

Current Price per Share
INR3,445.30
Expected price per share
INR3,239 - INR3,833
How sure are you?
50%

1. Valuation of Divi's Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR3,445.30

Intrinsic Value Per Share

INR459.50 - INR1,552.34

Total Value Per Share

INR940.43 - INR2,033.27

2. Growth of Divi's Laboratories Limited (5 min.)




Is Divi's Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1.5b$1.4b$124.6m8.1%

How much money is Divi's Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money$218.8m$355.2m-$136.4m-62.4%
Net Profit Margin23.5%33.6%--

How much money comes from the company's main activities?

3. Financial Health of Divi's Laboratories Limited (5 min.)




What can you expect buying and holding a share of Divi's Laboratories Limited? (5 min.)

Welcome investor! Divi's Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Divi's Laboratories Limited.

What can you expect buying and holding a share of Divi's Laboratories Limited?

First you should know what it really means to hold a share of Divi's Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Divi's Laboratories Limited is INR3,445. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Divi's Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Divi's Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR480.93. Based on the TTM, the Book Value Change Per Share is INR39.13 per quarter. Based on the YOY, the Book Value Change Per Share is INR91.67 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR30.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Divi's Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.820.0%0.820.0%1.340.0%0.860.0%0.640.0%
Usd Book Value Change Per Share0.470.0%0.470.0%1.100.0%0.620.0%0.460.0%
Usd Dividend Per Share0.360.0%0.360.0%0.240.0%0.290.0%0.230.0%
Usd Total Gains Per Share0.830.0%0.830.0%1.340.0%0.910.0%0.690.0%
Usd Price Per Share33.88-33.88-52.82-34.90-24.47-
Price to Earnings Ratio41.11-41.11-39.47-40.17-37.53-
Price-to-Total Gains Ratio40.84-40.84-39.42-38.05-36.15-
Price to Book Ratio5.87-5.87-9.96-7.98-7.98-
Price-to-Total Gains Ratio40.84-40.84-39.42-38.05-36.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share41.3436
Number of shares24
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.360.29
Usd Book Value Change Per Share0.470.62
Usd Total Gains Per Share0.830.91
Gains per Quarter (24 shares)19.9121.79
Gains per Year (24 shares)79.6487.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1354570285977
2699015056119164
310413523083178251
4138180310111238338
5173225390139297425
6207271470167356512
7242316550195416599
8276361630222475686
9311406710250534773
10346451790278594860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.01.094.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%

Fundamentals of Divi's Laboratories Limited

About Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-03-26 17:06:07.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Divi's Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Divi's Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 23.5% means that ₹0.23 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Divi's Laboratories Limited:

  • The MRQ is 23.5%. The company is making a huge profit. +2
  • The TTM is 23.5%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ23.5%TTM23.5%0.0%
TTM23.5%YOY33.6%-10.2%
TTM23.5%5Y28.0%-4.6%
5Y28.0%10Y27.7%+0.4%
1.1.2. Return on Assets

Shows how efficient Divi's Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 12.6% Return on Assets means that Divi's Laboratories Limited generated ₹0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Divi's Laboratories Limited:

  • The MRQ is 12.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ12.6%TTM12.6%0.0%
TTM12.6%YOY22.1%-9.5%
TTM12.6%5Y17.2%-4.6%
5Y17.2%10Y17.9%-0.7%
1.1.3. Return on Equity

Shows how efficient Divi's Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.3% Return on Equity means Divi's Laboratories Limited generated ₹0.14 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Divi's Laboratories Limited:

  • The MRQ is 14.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY25.2%-11.0%
TTM14.3%5Y19.8%-5.5%
5Y19.8%10Y21.0%-1.2%

1.2. Operating Efficiency of Divi's Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Divi's Laboratories Limited is operating .

  • Measures how much profit Divi's Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 30.5% means the company generated ₹0.31  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Divi's Laboratories Limited:

  • The MRQ is 30.5%. The company is operating very efficient. +2
  • The TTM is 30.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.5%TTM30.5%0.0%
TTM30.5%YOY41.9%-11.4%
TTM30.5%5Y36.6%-6.1%
5Y36.6%10Y36.0%+0.6%
1.2.2. Operating Ratio

Measures how efficient Divi's Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are ₹0.74 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.739. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.739. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.739TTM0.7390.000
TTM0.739YOY0.594+0.145
TTM0.7395Y0.657+0.082
5Y0.65710Y0.661-0.004

1.3. Liquidity of Divi's Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Divi's Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 8.46 means the company has ₹8.46 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 8.457. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.457. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.457TTM8.4570.000
TTM8.457YOY6.985+1.471
TTM8.4575Y6.307+2.150
5Y6.30710Y5.774+0.533
1.3.2. Quick Ratio

Measures if Divi's Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 9.23 means the company can pay off ₹9.23 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 9.226. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.226. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.226TTM9.2260.000
TTM9.226YOY5.715+3.512
TTM9.2265Y5.443+3.783
5Y5.44310Y5.183+0.260

1.4. Solvency of Divi's Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Divi's Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Divi's Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.12 means that Divi's Laboratories Limited assets are financed with 11.6% credit (debt) and the remaining percentage (100% - 11.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.116. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.116. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.116TTM0.1160.000
TTM0.116YOY0.123-0.007
TTM0.1165Y0.131-0.015
5Y0.13110Y0.146-0.015
1.4.2. Debt to Equity Ratio

Measures if Divi's Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 13.1% means that company has ₹0.13 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Divi's Laboratories Limited:

  • The MRQ is 0.131. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.131. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.131TTM0.1310.000
TTM0.131YOY0.140-0.009
TTM0.1315Y0.151-0.020
5Y0.15110Y0.172-0.021

2. Market Valuation of Divi's Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Divi's Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Divi's Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 41.11 means the investor is paying ₹41.11 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Divi's Laboratories Limited:

  • The EOD is 50.161. Based on the earnings, the company is expensive. -2
  • The MRQ is 41.106. Based on the earnings, the company is overpriced. -1
  • The TTM is 41.106. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD50.161MRQ41.106+9.055
MRQ41.106TTM41.1060.000
TTM41.106YOY39.474+1.632
TTM41.1065Y40.166+0.940
5Y40.16610Y37.528+2.638
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Divi's Laboratories Limited:

  • The EOD is 46.037. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 37.726. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 37.726. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD46.037MRQ37.726+8.311
MRQ37.726TTM37.7260.000
TTM37.726YOY97.498-59.771
TTM37.7265Y409.130-371.404
5Y409.13010Y237.371+171.759
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Divi's Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.87 means the investor is paying ₹5.87 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Divi's Laboratories Limited:

  • The EOD is 7.164. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.871. Based on the equity, the company is overpriced. -1
  • The TTM is 5.871. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.164MRQ5.871+1.293
MRQ5.871TTM5.8710.000
TTM5.871YOY9.964-4.093
TTM5.8715Y7.981-2.110
5Y7.98110Y7.979+0.002
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Divi's Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--39.13539.1350%91.671-57%51.549-24%38.673+1%
Book Value Per Share--480.926480.9260%441.791+9%362.053+33%264.007+82%
Current Ratio--8.4578.4570%6.985+21%6.307+34%5.774+46%
Debt To Asset Ratio--0.1160.1160%0.123-6%0.131-12%0.146-20%
Debt To Equity Ratio--0.1310.1310%0.140-7%0.151-13%0.172-24%
Dividend Per Share--30.00030.0000%20.000+50%24.127+24%18.923+59%
Eps--68.68568.6850%111.518-38%71.552-4%53.436+29%
Free Cash Flow Per Share--74.83874.8380%45.150+66%33.722+122%27.205+175%
Free Cash Flow To Equity Per Share--44.80944.8090%25.094+79%13.366+235%11.381+294%
Gross Profit Margin--0.9380.9380%0.957-2%0.943-1%0.9410%
Intrinsic Value_10Y_max--1552.340--------
Intrinsic Value_10Y_min--459.504--------
Intrinsic Value_1Y_max--75.290--------
Intrinsic Value_1Y_min--32.283--------
Intrinsic Value_3Y_max--287.387--------
Intrinsic Value_3Y_min--109.492--------
Intrinsic Value_5Y_max--573.236--------
Intrinsic Value_5Y_min--199.803--------
Market Cap914620318137.600+18%749511878563.200749511878563.2000%1168607776233.600-36%772002411565.440-3%541370649916.608+38%
Net Profit Margin--0.2350.2350%0.336-30%0.280-16%0.277-15%
Operating Margin--0.3050.3050%0.419-27%0.366-17%0.360-15%
Operating Ratio--0.7390.7390%0.594+24%0.657+13%0.661+12%
Pb Ratio7.164+18%5.8715.8710%9.964-41%7.981-26%7.979-26%
Pe Ratio50.161+18%41.10641.1060%39.474+4%40.166+2%37.528+10%
Price Per Share3445.300+18%2823.3502823.3500%4402.050-36%2908.070-3%2039.299+38%
Price To Free Cash Flow Ratio46.037+18%37.72637.7260%97.498-61%409.130-91%237.371-84%
Price To Total Gains Ratio49.834+18%40.83840.8380%39.420+4%38.054+7%36.152+13%
Quick Ratio--9.2269.2260%5.715+61%5.443+70%5.183+78%
Return On Assets--0.1260.1260%0.221-43%0.172-27%0.179-29%
Return On Equity--0.1430.1430%0.252-43%0.198-28%0.210-32%
Total Gains Per Share--69.13569.1350%111.671-38%75.675-9%57.596+20%
Usd Book Value--1532050800.0001532050800.0000%1407381600.000+9%1153366800.000+33%841026595.200+82%
Usd Book Value Change Per Share--0.4700.4700%1.100-57%0.619-24%0.464+1%
Usd Book Value Per Share--5.7715.7710%5.301+9%4.345+33%3.168+82%
Usd Dividend Per Share--0.3600.3600%0.240+50%0.290+24%0.227+59%
Usd Eps--0.8240.8240%1.338-38%0.859-4%0.641+29%
Usd Free Cash Flow--238405200.000238405200.0000%143832000.000+66%107424240.000+122%86666574.000+175%
Usd Free Cash Flow Per Share--0.8980.8980%0.542+66%0.405+122%0.326+175%
Usd Free Cash Flow To Equity Per Share--0.5380.5380%0.301+79%0.160+235%0.137+294%
Usd Market Cap10975443817.651+18%8994142542.7588994142542.7580%14023293314.803-36%9264028938.785-3%6496447798.999+38%
Usd Price Per Share41.344+18%33.88033.8800%52.825-36%34.897-3%24.472+38%
Usd Profit--218805600.000218805600.0000%355254000.000-38%227937600.000-4%170058429.600+29%
Usd Revenue--932101200.000932101200.0000%1055907600.000-12%804481680.000+16%609651118.800+53%
Usd Total Gains Per Share--0.8300.8300%1.340-38%0.908-9%0.691+20%
 EOD+4 -4MRQTTM+0 -0YOY+18 -185Y+19 -1710Y+28 -8

3.2. Fundamental Score

Let's check the fundamental score of Divi's Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1550.161
Price to Book Ratio (EOD)Between0-17.164
Net Profit Margin (MRQ)Greater than00.235
Operating Margin (MRQ)Greater than00.305
Quick Ratio (MRQ)Greater than19.226
Current Ratio (MRQ)Greater than18.457
Debt to Asset Ratio (MRQ)Less than10.116
Debt to Equity Ratio (MRQ)Less than10.131
Return on Equity (MRQ)Greater than0.150.143
Return on Assets (MRQ)Greater than0.050.126
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Divi's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.285
Ma 20Greater thanMa 503,487.555
Ma 50Greater thanMa 1003,598.244
Ma 100Greater thanMa 2003,666.413
OpenGreater thanClose3,367.050
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets144,387,700
Total Liabilities16,716,800
Total Stockholder Equity127,670,900
 As reported
Total Liabilities 16,716,800
Total Stockholder Equity+ 127,670,900
Total Assets = 144,387,700

Assets

Total Assets144,387,700
Total Current Assets93,117,400
Long-term Assets51,270,300
Total Current Assets
Cash And Cash Equivalents 1,697,000
Short-term Investments 40,494,600
Net Receivables 18,904,000
Inventory 30,004,100
Other Current Assets 2,017,700
Total Current Assets  (as reported)93,117,400
Total Current Assets  (calculated)93,117,400
+/-0
Long-term Assets
Property Plant Equipment 49,292,000
Intangible Assets 52,800
Other Assets 956,700
Long-term Assets  (as reported)51,270,300
Long-term Assets  (calculated)50,301,500
+/- 968,800

Liabilities & Shareholders' Equity

Total Current Liabilities11,010,800
Long-term Liabilities5,706,000
Total Stockholder Equity127,670,900
Total Current Liabilities
Short-term Debt 4,900
Accounts payable 7,625,100
Other Current Liabilities 2,875,600
Total Current Liabilities  (as reported)11,010,800
Total Current Liabilities  (calculated)10,505,600
+/- 505,200
Long-term Liabilities
Long term Debt Total 27,700
Capital Lease Obligations 32,600
Long-term Liabilities  (as reported)5,706,000
Long-term Liabilities  (calculated)60,300
+/- 5,645,700
Total Stockholder Equity
Common Stock530,900
Retained Earnings 109,581,100
Accumulated Other Comprehensive Income 16,760,100
Capital Surplus 798,800
Total Stockholder Equity (as reported)127,670,900
Total Stockholder Equity (calculated)127,670,900
+/-0
Other
Capital Stock530,900
Cash And Equivalents1,407,700
Cash and Short Term Investments 42,191,600
Common Stock Shares Outstanding 265,469
Current Deferred Revenue505,200
Liabilities and Stockholders Equity 144,387,700
Net Debt -1,664,400
Net Invested Capital 127,670,900
Net Working Capital 82,106,600
Property Plant and Equipment Gross 49,292,000
Short Long Term Debt Total 32,600



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-31
> Total Assets 
6,490,527
8,435,521
11,787,213
15,482,502
18,588,541
22,747,760
27,566,574
31,387,646
37,104,917
44,051,454
49,684,357
61,585,337
67,831,500
80,382,500
85,357,000
107,740,700
133,747,100
144,387,700
144,387,700133,747,100107,740,70085,357,00080,382,50067,831,50061,585,33749,684,35744,051,45437,104,91731,387,64627,566,57422,747,76018,588,54115,482,50211,787,2138,435,5216,490,527
   > Total Current Assets 
3,539,142
4,239,273
6,185,775
7,670,800
8,039,907
10,298,769
17,509,483
18,641,115
22,729,850
27,723,979
30,946,495
40,105,147
45,351,200
46,500,500
46,798,300
61,747,100
83,515,000
93,117,400
93,117,40083,515,00061,747,10046,798,30046,500,50045,351,20040,105,14730,946,49527,723,97922,729,85018,641,11517,509,48310,298,7698,039,9077,670,8006,185,7754,239,2733,539,142
       Cash And Cash Equivalents 
105,123
183,399
142,060
147,850
164,616
176,728
309,355
119,858
150,853
176,211
687,233
207,869
251,500
130,000
431,500
20,303,200
12,147,600
1,697,000
1,697,00012,147,60020,303,200431,500130,000251,500207,869687,233176,211150,853119,858309,355176,728164,616147,850142,060183,399105,123
       Short-term Investments 
0
0
555,650
0
0
0
5,425,463
4,082,444
5,022,964
7,335,790
8,039,970
16,358,198
18,892,800
13,983,400
9,823,600
546,400
15,270,100
40,494,600
40,494,60015,270,100546,4009,823,60013,983,40018,892,80016,358,1988,039,9707,335,7905,022,9644,082,4445,425,463000555,65000
       Net Receivables 
0
0
0
0
0
0
0
0
7,298,139
7,508,699
8,901,353
9,392,900
11,332,900
12,964,900
15,990,400
17,913,300
25,635,600
18,904,000
18,904,00025,635,60017,913,30015,990,40012,964,90011,332,9009,392,9008,901,3537,508,6997,298,13900000000
       Inventory 
1,838,588
2,135,089
2,814,148
4,212,815
4,985,044
5,717,055
6,789,626
8,356,942
9,324,176
11,626,402
12,078,277
13,199,127
13,506,700
17,723,400
18,638,600
21,452,300
28,286,200
30,004,100
30,004,10028,286,20021,452,30018,638,60017,723,40013,506,70013,199,12712,078,27711,626,4029,324,1768,356,9426,789,6265,717,0554,985,0444,212,8152,814,1482,135,0891,838,588
       Other Current Assets 
1,595,431
1,920,785
2,673,917
3,310,135
2,890,247
4,404,986
4,985,039
6,081,871
8,231,857
8,585,576
10,141,015
10,339,953
12,700,200
14,663,700
991,500
1,531,900
2,175,500
2,017,700
2,017,7002,175,5001,531,900991,50014,663,70012,700,20010,339,95310,141,0158,585,5768,231,8576,081,8714,985,0394,404,9862,890,2473,310,1352,673,9171,920,7851,595,431
   > Long-term Assets 
2,951,385
4,196,248
5,601,438
7,811,702
10,548,634
12,448,991
10,057,091
12,746,531
14,375,067
16,327,475
18,737,862
21,480,190
22,480,300
33,882,000
38,558,700
45,993,600
50,232,100
51,270,300
51,270,30050,232,10045,993,60038,558,70033,882,00022,480,30021,480,19018,737,86216,327,47514,375,06712,746,53110,057,09112,448,99110,548,6347,811,7025,601,4384,196,2482,951,385
       Property Plant Equipment 
2,148,654
3,813,777
4,970,591
5,898,642
6,135,884
7,186,410
9,199,942
12,121,308
13,663,258
15,231,226
16,997,535
19,995,011
21,094,000
25,756,300
36,979,300
44,095,400
47,874,900
49,292,000
49,292,00047,874,90044,095,40036,979,30025,756,30021,094,00019,995,01116,997,53515,231,22613,663,25812,121,3089,199,9427,186,4106,135,8845,898,6424,970,5913,813,7772,148,654
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
120
100
100
5,472,600
0
0
0
0
00005,472,6001001001200000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
39,542
29,270
32,539
65,500
40,500
36,000
49,500
74,900
52,800
52,80074,90049,50036,00040,50065,50032,53929,27039,542000000000
       Long-term Assets Other 
802,731
382,471
630,847
1,913,060
4,412,750
5,262,581
5,468,845
625,223
711,809
1,056,707
9,709,545
17,775,135
20,203,200
16,572,600
11,323,100
2,348,200
16,930,100
40,996,300
40,996,30016,930,1002,348,20011,323,10016,572,60020,203,20017,775,1359,709,5451,056,707711,809625,2235,468,8455,262,5814,412,7501,913,060630,847382,471802,731
> Total Liabilities 
3,091,788
3,081,395
3,173,243
3,068,658
3,410,503
4,772,985
6,251,351
6,381,680
7,471,420
9,097,856
6,807,399
8,011,394
8,583,500
10,811,000
12,257,800
14,794,600
16,465,300
16,716,800
16,716,80016,465,30014,794,60012,257,80010,811,0008,583,5008,011,3946,807,3999,097,8567,471,4206,381,6806,251,3514,772,9853,410,5033,068,6583,173,2433,081,3953,091,788
   > Total Current Liabilities 
1,311,294
1,264,694
1,929,928
2,110,085
2,607,901
4,042,132
5,537,835
5,544,538
6,274,059
7,755,259
5,195,034
6,594,478
6,507,200
8,467,500
9,268,300
11,124,600
11,955,500
11,010,800
11,010,80011,955,50011,124,6009,268,3008,467,5006,507,2006,594,4785,195,0347,755,2596,274,0595,544,5385,537,8354,042,1322,607,9012,110,0851,929,9281,264,6941,311,294
       Short-term Debt 
0
0
0
1,620,646
0
0
502,037
309,710
168,735
255,718
420,039
357,385
631,100
1,056,000
343,800
11,400
8,200
4,900
4,9008,20011,400343,8001,056,000631,100357,385420,039255,718168,735309,710502,037001,620,646000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
184,241
5,006
5,830
357,385
631,100
1,056,000
336,300
3,500
0
0
003,500336,3001,056,000631,100357,3855,8305,006184,24100000000
       Accounts payable 
0
0
1,293,661
0
1,503,384
2,137,093
1,595,397
1,604,440
1,517,048
2,268,657
2,326,905
3,838,573
4,112,100
4,922,600
5,907,200
7,632,000
7,957,000
7,625,100
7,625,1007,957,0007,632,0005,907,2004,922,6004,112,1003,838,5732,326,9052,268,6571,517,0481,604,4401,595,3972,137,0931,503,38401,293,66100
       Other Current Liabilities 
1,311,294
1,264,694
636,267
489,439
1,104,517
1,905,039
3,440,401
3,594,307
4,548,949
5,174,577
2,380,461
2,310,316
1,764,000
3,500
5,400
-47,200
3,824,000
2,875,600
2,875,6003,824,000-47,2005,4003,5001,764,0002,310,3162,380,4615,174,5774,548,9493,594,3073,440,4011,905,0391,104,517489,439636,2671,264,6941,311,294
   > Long-term Liabilities 
1,780,494
1,816,701
1,243,315
958,573
802,602
730,853
713,516
837,142
1,197,361
1,342,597
1,612,365
1,416,916
2,076,300
2,343,500
2,989,500
3,670,000
4,509,800
5,706,000
5,706,0004,509,8003,670,0002,989,5002,343,5002,076,3001,416,9161,612,3651,342,5971,197,361837,142713,516730,853802,602958,5731,243,3151,816,7011,780,494
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,700
36,900
28,700
27,700
27,70028,70036,90044,70000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
1,181,855
1,394,429
888,366
1,416,900
2,076,300
2,343,500
2,944,800
3,633,100
4,481,100
0
04,481,1003,633,1002,944,8002,343,5002,076,3001,416,900888,3661,394,4291,181,85500000000
> Total Stockholder Equity
3,398,739
5,354,126
8,613,970
12,413,844
15,178,038
17,974,775
21,315,223
25,005,966
29,633,497
34,953,598
42,876,958
53,573,943
59,248,000
69,571,500
73,099,200
92,946,100
117,281,800
127,670,900
127,670,900117,281,80092,946,10073,099,20069,571,50059,248,00053,573,94342,876,95834,953,59829,633,49725,005,96621,315,22317,974,77515,178,03812,413,8448,613,9705,354,1263,398,739
   Common Stock
128,187
129,114
129,114
129,516
264,288
265,191
265,469
265,469
265,469
265,469
530,937
530,937
530,900
530,900
530,900
530,900
530,900
530,900
530,900530,900530,900530,900530,900530,900530,937530,937265,469265,469265,469265,469265,191264,288129,516129,114129,114128,187
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 
-870,869
-1,094,962
-1,451,062
-1,929,008
-2,430,955
-2,957,671
-3,536,372
-4,296,333
-5,184,972
-6,435,167
-7,550,501
-8,747,023
-3,713,300
-5,374,700
13,826,700
15,639,200
16,063,600
16,760,100
16,760,10016,063,60015,639,20013,826,700-5,374,700-3,713,300-8,747,023-7,550,501-6,435,167-5,184,972-4,296,333-3,536,372-2,957,671-2,430,955-1,929,008-1,451,062-1,094,962-870,869
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
798,800
798,800
798,800
798,800
798,800
798,800
798,800
798,800798,800798,800798,800798,800798,800798,80000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
4,141,421
6,319,974
9,935,918
14,213,336
17,344,705
20,667,255
8,605,792
29,036,830
34,553,000
41,123,296
49,896,522
21,535,787
15,252,000
12,911,800
798,800
798,800
798,800
798,800
798,800798,800798,800798,80012,911,80015,252,00021,535,78749,896,52241,123,29634,553,00029,036,8308,605,79220,667,25517,344,70514,213,3369,935,9186,319,9744,141,421



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue77,675,100
Cost of Revenue-30,537,200
Gross Profit47,137,90047,137,900
 
Operating Income (+$)
Gross Profit47,137,900
Operating Expense-26,891,500
Operating Income23,693,00020,246,400
 
Operating Expense (+$)
Research Development300,500
Selling General Administrative1,249,300
Selling And Marketing Expenses1,138,200
Operating Expense26,891,5002,688,000
 
Net Interest Income (+$)
Interest Income3,389,700
Interest Expense-6,700
Other Finance Cost-3,389,700
Net Interest Income-6,700
 
Pretax Income (+$)
Operating Income23,693,000
Net Interest Income-6,700
Other Non-Operating Income Expenses0
Income Before Tax (EBT)23,686,30023,699,700
EBIT - interestExpense = 23,686,300
23,686,300
18,240,500
Interest Expense6,700
Earnings Before Interest and Taxes (EBIT)23,693,00023,693,000
Earnings Before Interest and Taxes (EBITDA)27,124,800
 
After tax Income (+$)
Income Before Tax23,686,300
Tax Provision-5,452,500
Net Income From Continuing Ops18,233,80018,233,800
Net Income18,233,800
Net Income Applicable To Common Shares18,233,800
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses57,428,700
Total Other Income/Expenses Net-6,7006,700
 

Technical Analysis of Divi's Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Divi's Laboratories Limited. The general trend of Divi's Laboratories Limited is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Divi's Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Divi's Laboratories Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3,614 < 3,652 < 3,833.

The bearish price targets are: 3,411 > 3,295 > 3,239.

Tweet this
Divi's Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Divi's Laboratories Limited. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Divi's Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Divi's Laboratories Limited. The current macd is -58.75283206.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Divi's Laboratories Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Divi's Laboratories Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Divi's Laboratories Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Divi's Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartDivi's Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Divi's Laboratories Limited. The current adx is 25.09.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Divi's Laboratories Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Divi's Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Divi's Laboratories Limited. The current sar is 3,522.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Divi's Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Divi's Laboratories Limited. The current rsi is 42.29. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Divi's Laboratories Limited Daily Relative Strength Index (RSI) ChartDivi's Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Divi's Laboratories Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Divi's Laboratories Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Divi's Laboratories Limited Daily Stochastic Oscillator ChartDivi's Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Divi's Laboratories Limited. The current cci is -93.21298831.

Divi's Laboratories Limited Daily Commodity Channel Index (CCI) ChartDivi's Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Divi's Laboratories Limited. The current cmo is -10.95464627.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Divi's Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartDivi's Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Divi's Laboratories Limited. The current willr is -68.4489323.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Divi's Laboratories Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Divi's Laboratories Limited Daily Williams %R ChartDivi's Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Divi's Laboratories Limited.

Divi's Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Divi's Laboratories Limited. The current atr is 73.86.

Divi's Laboratories Limited Daily Average True Range (ATR) ChartDivi's Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Divi's Laboratories Limited. The current obv is -6,314,556.

Divi's Laboratories Limited Daily On-Balance Volume (OBV) ChartDivi's Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Divi's Laboratories Limited. The current mfi is 40.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Divi's Laboratories Limited Daily Money Flow Index (MFI) ChartDivi's Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Divi's Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Divi's Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Divi's Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.285
Ma 20Greater thanMa 503,487.555
Ma 50Greater thanMa 1003,598.244
Ma 100Greater thanMa 2003,666.413
OpenGreater thanClose3,367.050
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Divi's Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Divi's Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Divi's Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Divi's Laboratories Limited

I send you an email if I find something interesting about Divi's Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Divi's Laboratories Limited.

Receive notifications about Divi's Laboratories Limited in your mailbox!